脊髄刺激装置（SCS）の世界市場：洞察、競合情勢、市場予測：2030年

世界の脊髄刺激装置（SCS）の市場規模は、2023年に22億5,000万米ドルとなりました。同市場は、2024年から2030年までの予測期間中に8.70％のCAGRで拡大し、2030年には37億2,000万米ドルに達すると予測されています。脊髄刺激装置（SCS）の需要は、主に慢性疼痛や肩、脚、膝の神経障害性疼痛の患者数の増加に起因しています。非侵襲的で、標的の痛みを取り除き、患者の不快感を軽減し、副作用のない技術的に進歩した装置が、世界の脊髄刺激装置（SCS）市場の成長を後押ししていると思われます。さらに、製品の商業化および市場投入に関する政府の有利な規制や高齢者人口の増加が、脊髄刺激装置（SCS）市場の成長を促進する要因の一部となっています。

怪我や外傷による慢性的な腰痛（LBP）や神経障害性疼痛に罹患する患者の有病率の増加は、予測期間中に脊髄刺激装置市場を強化すると予想されます。

米国疾病予防管理センター（CDC）によると、LBPは世界中で他のどの疾患よりも多くの障害を引き起こしている非常に一般的な疾患です。

さらに、米国カイロプラクティック協会が実施した最新の調査によると、人口の最大80％が人生のある時期に腰痛を経験すると推定されています。また、同調査によると、腰痛の大半は腰の手術の失敗が原因であると推定されています。腰の手術の失敗の統計によると、失敗した腰痛症患者の10～40％が罹患しています。

さらに、交通事故や転倒などによる外傷の増加は、腰や脊椎の損傷、椎間板ヘルニアなどを引き起こす可能性が高く、脊髄刺激装置の需要をさらに増加させるとみられています。

世界保健機関（WHO）2021年発表のデータによると、毎年世界中で25万人から50万人が脊髄損傷（SCI）を負っており、脊髄損傷の大部分は交通事故、転倒、暴力によるものです。

当レポートでは、世界の脊髄刺激装置（SCS）市場について調査し、市場の概要とともに、製品別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 脊髄刺激装置（SCS）市場レポートのイントロダクション

第2章 脊髄刺激装置（SCS）市場のエグゼクティブサマリー

第3章 規制分析

• 米国
• 欧州
• 日本
• 中国

第4章 脊髄刺激装置（SCS）市場の主な要因分析

• 脊髄刺激装置（SCS）市場の促進要因
• 脊髄刺激装置（SCS）市場の抑制要因と課題
• 脊髄刺激装置（SCS）市場の機会

第5章 脊髄刺激装置（SCS）におけるポーターのファイブフォース分析

第6章 脊髄刺激装置（SCS）市場概要

• 製品別
• 用途別
• エンドユーザー別
• 地域別

第7章 脊髄刺激装置（SCS）の企業と製品プロファイル

• Boston Scientific Corporation
• Medtronic PLC
• Abbott Laboratories
• Nevro Corp.
• Cirtec Medical
• Stimwave LLC
• NeuroSigma, Inc.
• Synapse Biomedical, Inc.
• Greatbatch, Inc.
• Saluda Medical Pty Ltd.
• Beijing PINS Medical Co., Ltd.

第8章 KOL の見解

第9章 プロジェクトのアプローチ

第10章 DelveInsightのサービス内容

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Spinal Cord Stimulators (SCS) Market in Global (2021-2030)
• Table 3: Spinal Cord Stimulators (SCS) Market in Global by Product (2021-2030)
• Table 4: Spinal Cord Stimulators (SCS) Market in Global by Application (2021-2030)
• Table 5: Spinal Cord Stimulators (SCS) Market in Global by End-User (2021-2030)
• Table 6: Spinal Cord Stimulators (SCS) Market in Global by Geography (2021-2030)
• Table 7: Spinal Cord Stimulators (SCS) Market in North America (2021-2030)
• Table 8: Spinal Cord Stimulators (SCS) Market in the US (2021-2030)
• Table 9: Spinal Cord Stimulators (SCS) Market in Canada (2021-2030)
• Table 10: Spinal Cord Stimulators (SCS) Market in Mexico (2021-2030)
• Table 11: Spinal Cord Stimulators (SCS) Market in Europe (2021-2030)
• Table 12: Spinal Cord Stimulators (SCS) Market in France (2021-2030)
• Table 13: Spinal Cord Stimulators (SCS) Market in Germany (2021-2030)
• Table 14: Spinal Cord Stimulators (SCS) Market in the United Kingdom (2021-2030)
• Table 15: Spinal Cord Stimulators (SCS) Market in Italy (2021-2030)
• Table 16: Spinal Cord Stimulators (SCS) Market in Spain (2021-2030)
• Table 17: Spinal Cord Stimulators (SCS) Market in Rest of Europe (2021-2030)
• Table 18: Spinal Cord Stimulators (SCS) Market in Asia-Pacific (2021-2030)
• Table 19: Spinal Cord Stimulators (SCS) Market in China (2021-2030)
• Table 20: Spinal Cord Stimulators (SCS) Market in Japan (2021-2030)
• Table 21: Spinal Cord Stimulators (SCS) Market in India (2021-2030)
• Table 22: Spinal Cord Stimulators (SCS) Market in Australia (2021-2030)
• Table 23: Spinal Cord Stimulators (SCS) Market South Korea (2021-2030)
• Table 24: Spinal Cord Stimulators (SCS) Market in Rest of Asia-Pacific (2021-2030)
• Table 25: Spinal Cord Stimulators (SCS) Market in the Rest of the World (2021-2030)
• Table 26: Spinal Cord Stimulators (SCS) Market in the Middle East (2021-2030)
• Table 27: Spinal Cord Stimulators (SCS) Market in Africa (2021-2030)
• Table 28: Spinal Cord Stimulators (SCS) Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Spinal Cord Stimulators (SCS) Market in Global (2021-2030)
• Figure 3: Spinal Cord Stimulators (SCS) Market in Global by Product (2021-2030)
• Figure 4: Spinal Cord Stimulators (SCS) Market in Global by Application (2021-2030)
• Figure 5: Spinal Cord Stimulators (SCS) Market in Global by End-User (2021-2030)
• Figure 6: Spinal Cord Stimulators (SCS) Market in Global by Geography (2021-2030)
• Figure 7: Spinal Cord Stimulators (SCS) Market in North America (2021-2030)
• Figure 8: Spinal Cord Stimulators (SCS) Market in the US (2021-2030)
• Figure 9: Spinal Cord Stimulators (SCS) Market in Canada (2021-2030)
• Figure 10: Spinal Cord Stimulators (SCS) Market in Mexico (2021-2030)
• Figure 11: Spinal Cord Stimulators (SCS) Market in Europe (2021-2030)
• Figure 12: Spinal Cord Stimulators (SCS) Market in France (2021-2030)
• Figure 13: Spinal Cord Stimulators (SCS) Market in Germany (2021-2030)
• Figure 14: Spinal Cord Stimulators (SCS) Market in the United Kingdom (2021-2030)
• Figure 15: Spinal Cord Stimulators (SCS) Market in Italy (2021-2030)
• Figure 16: Spinal Cord Stimulators (SCS) Market in Spain (2021-2030)
• Figure 17: Spinal Cord Stimulators (SCS) Market in Rest of Europe (2021-2030)
• Figure 18: Spinal Cord Stimulators (SCS) Market in Asia-Pacific (2021-2030)
• Figure 19: Spinal Cord Stimulators (SCS) Market in China (2021-2030)
• Figure 20: Spinal Cord Stimulators (SCS) Market in Japan (2021-2030)
• Figure 21: Spinal Cord Stimulators (SCS) Market in India (2021-2030)
• Figure 22: Spinal Cord Stimulators (SCS) Market in Australia (2021-2030)
• Figure 23: Spinal Cord Stimulators (SCS) Market in South Korea (2021-2030)
• Figure 24: Spinal Cord Stimulators (SCS) Market in Rest of Asia-Pacific (2021-2030)
• Figure 25: Spinal Cord Stimulators (SCS) Market in the Rest of the World (2021-2030)
• Figure 26: Spinal Cord Stimulators (SCS) Market in the Middle East (2021-2030)
• Figure 27: Spinal Cord Stimulators (SCS) Market in Africa (2021-2030)
• Figure 28: Spinal Cord Stimulators (SCS) Market in South America (2021-2030)
• Figure 29: Market Drivers
• Figure 30: Market Barriers
• Figure 31: Market Opportunities
• Figure 32: PORTER'S Five Force Analysis

Spinal Cord Stimulators (SCS) Market By Product (Rechargeable, Non-Rechargeable, and Others), Application (Failed Back Syndrome (FBS), Degenerative Disk Disease (DDD), Complex Regional Pain Syndrome (CRPS), and Others), End-User (Hospitals, Clinics, and Ambulatory Surgical Centers), and Geography is expected to grow at a steady CAGR forecast till 2030 owing to growing number of patients with chronic pain and technologically advanced devices

The global spinal cord stimulators (SCS) market was valued at USD 2.25 billion in 2023, growing at a CAGR of 8.70% during the forecast period from 2024 to 2030 to reach USD 3.72 billion by 2030. The demand for spinal cord stimulators (SCS) is primarily attributed to the growing number of patients with chronic pain, and neuropathic pain in the shoulder, legs, and knee. The technologically advanced devices that are non-invasive, eliminate targeted pains, and cause a reduction in patient discomfort, with no side effects are likely responsible for a boost in the global spinal cord stimulators (SCS) market growth. Moreover, favorable government regulations for commercialization and launching products in the market and the rising geriatric population are some of the factors responsible for propelling the growth of the spinal cord stimulators (SCS) market.

Spinal Cord Stimulators (SCS) Market Dynamics:

The rising prevalence of patients affected with chronic lower back pain (LBP) and neuropathic pain due to injuries and trauma is anticipated to bolster the market for spinal cord stimulators during the forecasted period.

According to the Centers for Disease Control and Prevention (CDC) 2022, LBP is a very common condition causing more disability around the world than any other condition.

Further, as per the latest study conducted by the American Chiropractic Association, it was estimated that up to 80% of the population will experience back pain at some time in their lives. According to the same source, it was estimated that the majority of people are suffering from LBP due to back surgery failure. Failed back surgery statistics show that anywhere from 10-40% of failed back syndrome patients are affected.

The International Association for the Study of Pain 2021, disability associated with Lower Back Pain increased in all age groups between 1990 and 2019 and was greatest in the 50-54 age group in 2019. Approximately 70% of years lost through disability were in working-aged people (20-65 years) in 2020.

Moreover, a rise in traumatic injuries due to road crashes falls, and others are likely to cause lower back and spine injuries, herniated discs, and others which will further increase the demand for Spinal Cord Stimulators.

As per the data published by the World Health Organization (WHO) 2021, every year between 250,000 and 500,000 people suffer a spinal cord injury (SCI) around the world and the majority of spinal cord injuries are due to road traffic crashes, falls, or violence.

In addition, in January 2020, Stimgenics developed a spinal cord stimulation waveform known as Differential Target Multiplexed Spinal Cord Stimulation. The therapy is delivered through Medtronic's Intellis platform and is a chronic pain treatment option. Such technological advancement in the field of spinal cord stimulators (SCS) is likely to boost the market for the same.

However, certain factors such as risks associated with the devices, and also the high cost of the devices pose a major hurdle to the growth of the spinal cord stimulators (SCS) market.

Spinal Cord Stimulators (SCS) Market Segment Analysis:

Spinal Cord Stimulators (SCS) market by Product (Rechargeable, Non-Rechargeable, Others), Spinal Cord Stimulators (SCS) market by Application (Failed Back Syndrome (FBS), Degenerative Disk Disease (DDD), Complex Regional Pain Syndrome (CRPS), Others), Spinal Cord Stimulators (SCS) market by End User (Hospitals, Clinics, Ambulatory Surgical Centers), and Spinal Cord Stimulators (SCS) market by Geography (North America, Europe, Asia-Pacific, and Rest of the World).

Spinal Cord Stimulators (SCS) market product segment, the Rechargeable market segment will hold the majority of the Global Spinal Cord Stimulators (SCS) market in 2020. The rapid growth of this product segment can be attributed to the growing demand due to significant cost-savings with the use of rechargeable stimulators as compared to non-rechargeable ones leading to the high adoption of these devices.

Moreover, most of the non-rechargeable SCS devices contain a battery that must eventually be surgically replaced but, with rechargeable SCS, the battery can theoretically last several years longer than with traditional SCS. Therefore, with the growing demand for disease treatment benefits, the market of Spinal Cord Stimulators (SCS), is expected to rise.

In addition, new product approvals are also likely to upsurge the spinal cord stimulators (SCS) market during the forecasted period. For instance, in February 2022, the US FDA approved Intellis(TM), a rechargeable stimulator for the treatment of chronic pain associated with diabetic peripheral neuropathy (DPN).

Additionally, a rechargeable SCS system is projected to require from 2.6 to 4.2 fewer battery generator replacements for battery depletion than a non-rechargeable SCS system.

Hence, all the above-mentioned factors are expected to drive the segment growth of the Spinal Cord Stimulators (SCS) market.

North America is expected to dominate the Overall Spinal Cord Stimulators (SCS) Market:

North America is expected to dominate the overall spinal cord stimulators (SCS) market during the forecast period. This can be attributed to the growing prevalence of lower back pain, the rising prevalence of spinal degenerative disc diseases, and others, thereby propelling the market of spinal cord stimulators in the United States.

As per the Back Pain Facts and Statistics, 2021, about 31 million Americans tend to experience lower back pain at any given time.

As per the Centers for Disease Control and Prevention (CDC) 2021, nearly 25% of United States adults reported lower back pain in the prior three months.

Also, according to the Back Pain Statistics 2021, nearly 30% of the United States population experienced lower back problems in the last three months of 2019.

Further, the United States represents the largest market worldwide supported by rising product launch and commercialization agreements among the key manufacturers and other companies which is anticipated to boost the market growth. For instance, in January 2021, the recent launch of Boston Scientific's WaveWriter Alpha portfolio of Spinal Cord Stimulator (SCS) systems, is expected to propel the market growth of Spinal Cord Stimulators (SCS).

Also, in August 2022, Abbott received the US Food and Drug Administration (FDA) approval for its new Proclaim(TM) Plus spinal cord stimulation (SCS) system featuring FlexBurst360(TM) therapy.

Thus, all the above-mentioned factors are anticipated to propel the market for spinal cord stimulators in the United States during the forecast period from 2023 -2028.

Spinal Cord Stimulators (SCS) Market Key Players:

Some of the key market players operating in the Spinal Cord Stimulators (SCS) market include Boston Scientific Corporation, Medtronic PLC, Abbott Laboratories, Nevro Corp., Cirtec Medical, Stimwave LLC, NeuroSigma, Inc., Synapse Biomedical, Inc., Greatbatch, Inc., Saluda Medical Pty Ltd., Beijing PINS Medical Co., Ltd., and others.

Recent Developmental Activities in the Spinal Cord Stimulators (SCS) Market:

In May 2022, Medtronic announced the launch of CareGuidePro, a new mobile application and web portal that serves as a virtual guide for patients throughout their spinal cord stimulation therapy journey.

In January 2022, Abbott announced the upcoming launch of NeuroSphere myPath, a digital health app designed to track and report on patient-perceived pain relief in chronic pain patients with physicians before the device implant.

In January 2022, The US Food and Drug Administration (FDA) approved two of Medtronic's existing technologies, Intellis and Vanta, for the treatment of pain associated with diabetic peripheral neuropathy (DPN).

Key Takeaways from the Spinal Cord Stimulators (SCS) Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global spinal cord stimulators (SCS) market.

Various opportunities are available for the other competitor in the spinal cord stimulators (SCS) market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for spinal cord stimulators (SCS) market growth in the coming future?

Target Audience Who can be benefited from this Spinal Cord Stimulator (SCS) Market Report Study

Spinal Cord Stimulators (SCS) providers

Research organizations and consulting companies

Spinal Cord Stimulators (SCS) related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in spinal cord stimulators (SCS)

Various End-Users want to know more about the spinal cord stimulators (SCS) market and the latest technological developments in the spinal cord stimulators (SCS) market.

Frequently Asked Questions for Spinal Cord Stimulators (SCS) Market:

1. What are spinal cord stimulators (SCS)?

A spinal cord stimulation device consists of a thin wire, which carries out current from the pulse generator to the nerve fibers of the spinal cord. These are mounted under the skin and transmit electrical signals to the spinal cord. This system is made up of a short wire that brings current to the nerve fibers of the spinal cord from a pulse generator. Therefore, machines for spinal cord stimulation help minimize discomfort due to electrical pulses and mask the signal of pain from affecting the brain.

2. What is the market for global spinal cord stimulators (SCS)?

The global spinal cord stimulators (SCS) market was valued at USD 2.25 billion in 2023, growing at a CAGR of 8.70% during the forecast period from 2024 to 2030 to reach USD 3.72 billion by 2030.

3. What are the drivers for the global spinal cord stimulators (SCS) market?

The major drivers driving the demand for spinal cord stimulators (SCS) are attributed to the rising technological advancements by key players, the growing burden of chronic diseases like failed back syndrome, chronic pain, and complex regional pain syndrome, reducing the burden of opioids and pain-relieving drugs intake, favorable government regulations, and increasing geriatric population among others.

4. Who are the key players operating in the global spinal cord stimulators (SCS) market?

Some of the key market players operating in the spinal cord stimulators (SCS) market include Boston Scientific Corporation, Medtronic PLC, Abbott Laboratories, Nevro Corp., Cirtec Medical, Stimwave LLC, NeuroSigma, Inc., Synapse Biomedical, Inc., Greatbatch, Inc., Saluda Medical Pty Ltd., Beijing PINS Medical Co., Ltd., and others.

5. Which region has the highest share in the spinal cord stimulators (SCS) market?

North America is expected to dominate the overall spinal cord stimulators (SCS) market during the forecast period, 2024 to 2030. This domination is due to the improved reimbursement policies by the government, and the high adoption of technological advancements owing to the rise in healthcare expenditure by the US government.

Table of Contents

1. Spinal Cord Stimulators (SCS) Market Report Introduction

2. Spinal Cord Stimulators (SCS) Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment

3. Regulatory Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Spinal Cord Stimulators (SCS) Market Key Factors Analysis

• 4.1. Spinal Cord Stimulators (SCS) Devices Market Drivers
  • 4.1.1. Rising technological advancements by key players
  • 4.1.2. Growing burden of chronic pain
  • 4.1.3. Favorable government regulations
  • 4.1.4. Increasing geriatric population
• 4.2. Spinal Cord Stimulators (SCS) Devices Market Restraints and Challenges
  • 4.2.1. High cost of the devices
  • 4.2.2. Complications associated with the technologically advanced devices
• 4.3. Spinal Cord Stimulators (SCS) Devices Market Opportunities
  • 4.3.1. Preference of these devices over spinal surgeries
  • 4.3.2. Development of non-invasive, compact, and advanced devices

5. Spinal Cord Stimulators (SCS) Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. Spinal Cord Stimulators (SCS) Market Layout

• 6.1. By Product
  • 6.1.1. Rechargeable
  • 6.1.2. Non-Rechargeable
  • 6.1.3. Others
• 6.2. By Application
  • 6.2.1. Failed Back Syndrome (FBS)
  • 6.2.2. Degenerative Disk Disease (DDD)
  • 6.2.3. Complex Regional Pain Syndrome (CRPS)
  • 6.2.4. Others
• 6.3. By End-User
  • 6.3.1. Hospitals
  • 6.3.2. Clinics
  • 6.3.3. Ambulatory Surgical Centers
• 6.4. By Geography
  • 6.4.1. North America Spinal Cord Stimulators (SCS) Market Size in USD million (2021-2030)
    • 6.4.1.1. United States Spinal Cord Stimulators (SCS) Market Size in USD million (2021-2030)
    • 6.4.1.2. Canada Spinal Cord Stimulators (SCS) Market Size in USD million (2021-2030)
    • 6.4.1.3. Mexico Spinal Cord Stimulators (SCS) Market Size in USD million (2021-2030)
  • 6.4.2. Europe Spinal Cord Stimulators (SCS) Market Size in USD million (2021-2030)
    • 6.4.2.1. France Spinal Cord Stimulators (SCS) Market Size in USD million (2021-2030)
    • 6.4.2.2. Germany Spinal Cord Stimulators (SCS) Market Size in USD million (2021-2030)
    • 6.4.2.3. United Kingdom Spinal Cord Stimulators (SCS) Market Size in USD million (2021-2030)
    • 6.4.2.4. Italy Spinal Cord Stimulators (SCS) Market Size in USD million (2021-2030)
    • 6.4.2.5. Spain Spinal Cord Stimulators (SCS) Market Size in USD million (2021-2030)
    • 6.4.2.6. Rest of Europe Spinal Cord Stimulators (SCS) Market Size in USD million (2021-2030)
  • 6.4.3. Asia-Pacific Spinal Cord Stimulators (SCS) Market Size in USD million (2021-2030)
    • 6.4.3.1. China Spinal Cord Stimulators (SCS) Market Size in USD million (2021-2030)
    • 6.4.3.2. Japan Spinal Cord Stimulators (SCS) Market Size in USD million (2021-2030)
    • 6.4.3.3. India Spinal Cord Stimulators (SCS) Market Size in USD million (2021-2030)
    • 6.4.3.4. Australia Spinal Cord Stimulators (SCS) Market Size in USD million (2021-2030)
    • 6.4.3.5. South Korea Spinal Cord Stimulators (SCS) Market Size in USD million (2021-2030)
    • 6.4.3.6. Rest of Asia-Pacific Spinal Cord Stimulators (SCS) Market Size in USD million (2021-2030)
  • 6.4.4. Rest of the World (RoW) Spinal Cord Stimulators (SCS) Market Size in USD million (2021-2030)
    • 6.4.4.1. Middle East Spinal Cord Stimulators (SCS) Market Size in USD million (2021-2030)
    • 6.4.4.2. Africa Spinal Cord Stimulators (SCS) Market Size in USD million (2021-2030)
    • 6.4.4.3. South America Spinal Cord Stimulators (SCS) Market Size in USD million (2021-2030)

7. Spinal Cord Stimulators (SCS) Company and Product Profiles

• 7.1. Boston Scientific Corporation
  • 7.1.1. Company Overview
  • 7.1.2. Company Snapshot
  • 7.1.3. Financial Overview
  • 7.1.4. Product Listing
  • 7.1.5. Entropy
• 7.2. Medtronic PLC
  • 7.2.1. Company Overview
  • 7.2.2. Company Snapshot
  • 7.2.3. Financial Overview
  • 7.2.4. Product Listing
  • 7.2.5. Entropy
• 7.3. Abbott Laboratories
  • 7.3.1. Company Overview
  • 7.3.2. Company Snapshot
  • 7.3.3. Financial Overview
  • 7.3.4. Product Listing
  • 7.3.5. Entropy
• 7.4. Nevro Corp.
  • 7.4.1. Company Overview
  • 7.4.2. Company Snapshot
  • 7.4.3. Financial Overview
  • 7.4.4. Product Listing
  • 7.4.5. Entropy
• 7.5. Cirtec Medical
  • 7.5.1. Company Overview
  • 7.5.2. Company Snapshot
  • 7.5.3. Financial Overview
  • 7.5.4. Product Listing
  • 7.5.5. Entropy
• 7.6. Stimwave LLC
  • 7.6.1. Company Overview
  • 7.6.2. Company Snapshot
  • 7.6.3. Financial Overview
  • 7.6.4. Product Listing
  • 7.6.5. Entropy
• 7.7. NeuroSigma, Inc.
  • 7.7.1. Company Overview
  • 7.7.2. Company Snapshot
  • 7.7.3. Financial Overview
  • 7.7.4. Product Listing
  • 7.7.5. Entropy
• 7.8. Synapse Biomedical, Inc.
  • 7.8.1. Company Overview
  • 7.8.2. Company Snapshot
  • 7.8.3. Financial Overview
  • 7.8.4. Product Listing
  • 7.8.5. Entropy
• 7.9. Greatbatch, Inc.
  • 7.9.1. Company Overview
  • 7.9.2. Company Snapshot
  • 7.9.3. Financial Overview
  • 7.9.4. Product Listing
  • 7.9.5. Entropy
• 7.10. Saluda Medical Pty Ltd.
  • 7.10.1. Company Overview
  • 7.10.2. Company Snapshot
  • 7.10.3. Financial Overview
  • 7.10.4. Product Listing
  • 7.10.5. Entropy
• 7.11. Beijing PINS Medical Co., Ltd.
  • 7.11.1. Company Overview
  • 7.11.2. Company Snapshot
  • 7.11.3. Financial Overview
  • 7.11.4. Product Listing
  • 7.11.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us